Author | Audrey Sternberg


With Patients’ Safety Top of Mind, Oncologists Develop Innovative Care Plans During Pandemic

May 25, 2020


"Our efforts in the cancer clinic have been driven by patient safety and also maintaining patient access to care. In the age of COVID-19, those 2 things are sometimes at odds with each other."

Hitting the Target: Rapid Evolution of Plasma Assays Continues to Move Genomic Profiling Toward More Efficient Testing Methods

May 20, 2020


"Liquid biopsy is useful at any time when a physician needs genomic information about their patient’s cancer in order to make a treatment decision."

BCG-Unresponsive NMIBC Responds to Intravesical Adenoviral Gene Therapy

May 15, 2020


"Intravesical nadofaragene firadenovec [recombinant adenovirus interferon alpha achieved a 53.4% CR rate in patients with BCG-unresponsive carcinoma in situ of the bladder."

Patients With EGFR Exon 20-Mutated NSCLC Demonstrate Response With Poziotinib

April 28, 2020


Interim findings of the ongoing phase II ZENITH20 trial demonstrated that poziotinib induced a 68.7% disease control rate when used as treatment of patients with pretreated non–small cell lung cancer harboring an EGFR exon 20 insertion.